FDA Inspection 1263510 — Agon Pharma Private Limited

Agon Pharma Private Limited — FEI 3007481629

The FDA completed an inspection of Agon Pharma Private Limited on January 31, 2025 in Pune. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 31, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pune (India)